Ian Hoban Joins Pilatus Clinical Services

Food and Healthcare Press Releases Thursday October 5, 2017 09:12
LONDON--5 Oct--PRNewswire/InfoQuest

Pilatus Clinical Services are delighted to announce another addition to our management team. Mr Ian Hoban, previously Commercial Manager at Eli Lilly, will now fulfil the role of Sales & Marketing Director. Ian has close to 30 years of experience in the pharmaceutical industry, acting in a variety of roles including those of senior leadership at both Pfizer and Eli Lilly.


In his most recent position, Ian was responsible for managing the commercial development of numerous therapeutic brands, from development through to product launch and ultimately to loss-of-exclusivity. Ian is well-versed in the pharmaceutical supply chain and understands how getting the optimal solution in place is fundamental to the delivery of successful project outcomes.

Ian is no stranger to the clinical trials supply arena. Before his function as a Business Development Director, he held a consultative role at a major pharmaceutical company; helping deliver added value to their customers and partners following the acquisition of a number of diversified businesses.

'Our commercial footprint is growing. With the incorporation of our sister company; PCS GmbH in Germany and future expansions in the pipeline, we are confident in achieving our goal of providing smarter comparator sourcing solutions to the clinical trial community. Myself, and the remaining board members are excited at the prospect of working with Ian to capitalise on these expansions and maximising Pilatus' brand in the comparator sourcing space,' said Julian Wolfe, Commercial Director at Pilatus Clinical Services.

Ian has a passion for collaboration and has seen how business partnerships can deliver strategic insight. At Pfizer UK, in the Established Products Business Unit, Ian oversaw the implementation of numerous techniques and witnessed how they transformed business outcomes in a highly competitive space.

This is another great advancement for the Pilatus group, improving our status as a leading service provider in comparator sourcing for clinical trials.
T: +44 (0) 1923 204310
Source: Pilatus Clinical Services Ltd.

Latest Press Release

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia...

Johnson Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan,...

Biotherm Hosts the First Biotherm Healing Summit

Biotherm hosted the first "Biotherm Healing Summit" on March 7. A symposium on the theme of skin & healing, focusing on major research that has evidenced the link between micro-organisms and skin health. Unveiling Life PlanktonTM, the healing...

Cardiologist Reccomends Top 3 Steps to Help Prevent Heart Disease in Thailand

Bangkok, In Thailand, an average of 150 people per day, or six people per hour die from heart disease according to the Ministry of Public Health who reported that from 2012 to 2016, the average number of deaths caused by heart disease was approximately...

Pilatus Clinical Services - German Subsidiary PCS GMBH Awarded WDL GDP Certificate

As part of Pilatus Clinical Services ongoing plans to strengthen its position in Europe and as part of establishing a Global footprint, the company has announced that following a recent inspection by the German regulatory authorities, its German...

Related Topics